Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Company research

Conexeu Sciences Inc.

CIK 2066836Updated Nov 6, 2026

SecurityCNXU · NASDAQ · equity

CNXU price & chart

Provider market data

Loading TradingView…

NASDAQ:CNXU on TradingView ↗

TradingView · Data may be delayed

About the company

The Company's proprietary formula, CXUTM, is an ECM scaffold device candidate protected by patents (collectively, the "Patents") in Australia, and the European Union (validated in Belgium, Switzerland, Germany, Spain, France, Great Britain, Ireland, Italy, and the Netherlands), Japan, and the USA, which form a critical barrier to entry and secure our competitive advantage in regenerative medicine.  Origin and ownership of the Company's core patent rights were assigned from the University. Patent protection in Canada for such proprietary ECM scaffold technology remains pending. The Patents are summarized in the table below:

424B4 · 2026-05-11 · 0001062993-26-002473

Company description from the cited filing.

In the news

Seeking Alpha

Recent filings

  1. D filing

    Items 06b

    D · 2026-11-05 · 0002060755-26-000066

  2. D filing

    Items 06b

    D · 2026-11-05 · 0002060755-26-000065

  3. 424B3 filing

    424B3 · 2026-10-29 · 0001062993-26-005604

  4. Unregistered Sales of Equity Securities · Other Events

    Items 3.02, 8.01, 9.01

    8-K · 2026-10-27 · 0001062993-26-005569

  5. D filing

    Items 06b

    D · 2026-10-21 · 0002060755-26-000061

Show 5 more recent filings

  1. 424B3 filing

    424B3 · 2026-10-21 · 0001062993-26-005440

  2. Unregistered Sales of Equity Securities

    Items 3.02, 9.01

    8-K · 2026-10-20 · 0001062993-26-005431

  3. D filing

    Items 06b

    D · 2026-09-29 · 0002060755-26-000059

  4. SCHEDULE 13D/A - filed by Sharpe Jeffrey Nathan regarding Conexeu Sciences Inc.

    SCHEDULE 13D/A · 2026-09-15 · 0001062993-26-004967

  5. D filing

    Items 06b

    D · 2026-09-15 · 0002060755-26-000058

Offerings

Registration 333-291845

424B4 · 2026-05-11 · 0001062993-26-002473

Terms from the governing filing for this registration; not a claim that the offering is open today.

Offering price
market-price
Ticker
CNXU

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.